EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
Giga-tronics Incorporated (OTCQB: GIGA) (the “Company”) reported net revenue for the fourth fiscal quarter ended March 30, 2019 of $3.5 million, a 50% increase as compared to $2.3 million for the same period of fiscal 2018. […]
– Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 –
[…]
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue” or “the Company”) (TSXV:CBLU) (FRANKFURT:0YA) announced today the launch of its Energy-as-a-Service (EaaS) for wireless power. This new subscription-based service provides […]
Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal […]
Multi-Center Phase III trial planned for 2019
[…]
PRINCETON, NJ – May 14, 2019 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]
Company provides Q1 2019 update and guidance. Upcoming interview with WSA. […]
Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day […]
DALLAS, TX, April 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NaturalShrimp, Inc. (SHMP) announced today that their order for two additional EC shrimp water treatment systems have arrived at their Lacoste, Texas, facility, near […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com